We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tiny Ingestible Sensor Monitors Drug Adherence

By HospiMedica International staff writers
Posted on 22 Jul 2015
A sensor the size of a grain of sand can now be used to monitor a patient’s adherence to medication and communicate the data to caregivers.

The Proteus Ingestible sensor is just 1 mm square in size, and is made mostly of silicon and miniature electronics. More...
It does not contain a battery, but is instead powered for a short amount of time by contact between two conductive materials and stomach acid. At that time, it sends a signal to the proprietary Proteus Patch—an adhesive patch worn on the torso—which records the exact time the medication was taken, as well as the unique identity of the drug. The ingestible sensor can be integrated with the medication itself.

Besides time of ingestion, the Proteus Patch can also record rest and heart rate, body position, and activity, and communicates the data to a mobile app via Bluetooth. With the patient’s consent, the information is then accessible to caregivers and clinicians, helping individuals develop and sustain healthy habits, families make better health choices, and clinicians provide more effective, data-driven care. The Proteus Ingestible sensor and Patch are products of Proteus Digital Health (Redwood City, CA, USA), and have been approved by the US Food and Drug Administration (FDA).

“The new system is the first time adherence data from Proteus’s system will integrate directly into an electronic data capture system,” said the company in a press statement. “It will allow clinical trial investigators access to accurate medication adherence data, something for which they currently rely on self-reporting and occasional lab tests.”

Related Links:

Proteus Digital Health



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.